|
Price and Volume
Detailed Quote
Compare to:
|
Top News
More News
New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
Today 12:20 EDT
from PR Newswire
Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II Trial
Today 10:41 EDT
New Data Presented In Late-Breaking Clinical Trial Session At EuroPCR Demonstrated Successful Deployment Of The Lotus™ Valve In The First 60 Patients With Minimal Paravalvular Regurgitation At 30 Days Read More
from PR Newswire
|
